Advanced heart failure due to cancer therapy.

Abstract

Certain chemotherapeutic agents and mediastinal irradiation can be cardiotoxic and place cancer survivors at risk for developing advanced heart failure (HF). Anthracyclines are the prototypical agents associated with left ventricular (LV) dysfunction. Newer agents including trastuzumab and certain tyrosine kinase inhibitors such as sunitinib can also cause… (More)
DOI: 10.1007/s11886-015-0570-3

Topics

3 Figures and Tables

Cite this paper

@article{Shah2015AdvancedHF, title={Advanced heart failure due to cancer therapy.}, author={Sachin Shah and Anju Nohria}, journal={Current cardiology reports}, year={2015}, volume={17 4}, pages={16} }